Magnesium Glycinate Sleep Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Glycinate Sleep Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Temporomandibular disorders (TMDs) are among the most common causes of chronic orofacial pain, with myalgia of the masticatory muscles being a major.Patients frequently present with persistent aching pain, muscle tenderness, and restricted jaw function, all of which significantly impair quality of life.While existing treatments are mainly symptomatic,emerging evidence suggests a role for electrolyte modulation. [Patil Shankargouda (2026); evidence level 1]
• Notably, a recent randomized controlled trial demonstrated that local magnesium sulphate injection into the masseter muscle significantly reduced pain intensity and improved function in TMD myalgia, providing a direct clinical link between electrolyte biology and orofacial pain.This observation highlights the potential for broader exploration of electrolyte-based interventions in TMD. [Patil Shankargouda (2026); evidence level 1]
• Despite its significance, standard serum magnesium testing is unreliable; patients may have normal serum levels of 0.75-0.95 mmol/L yet present with evidence of chronic, underlying deficiency. [Ahmed Sibtain (2026); evidence level 4]
• Evidence suggests that up to 42% of young adults exhibit undetected insufficiency and nearly half of the US population fails to meet the RDA of 300-400 mg/day. [Ahmed Sibtain (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium glycinate sleep meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Patil Shankargouda (2026). The Role of Electrolytes in Muscle Pain Syndromes: A Systematic Review and Meta-Analysis With Implications for Temporomandibular Disorder. DOI: 10.1016/j.identj.2026.109488. PMCID: PMC12994056. PMID: 41812583. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12994056/
• Ahmed Sibtain (2026). Magnesium - The Silent Partner or the Next Vitamin D? Shifting Paradigm in Mineral Metabolism in Health and Disease. PMCID: PMC12882071. PMID: 41659294. License: https://creativecommons.org/licenses/by-nc/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12882071/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.